Canopy selling German subsidiary for up to $180M, losing nearly half of purchase price

Mugglehead
By Nick LabaDec 15, 2021, 2:01 pm236 pts
Canadian pot giant Canopy Growth Corp. (TSX: WEED) (Nasdaq: GCG) is selling off a German cannabinoid pharmaceuticals subsidiary for around half of what it paid for it two years ago. On Wednesday, the company said it’s made a deal to “divest” C³ Cannabinoid Compound Company GmbH to Dermapharm Holding SE…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Missouri Marijuana Officials Are Reviewing Rules On Purchase Limits For Medical Patients 64

Texas Expands Patients’ Access to Medical Cannabis 54

Alabama Cannabis Regulators Grant Medical Marijuana Testing License To Foley-Based Lab 49

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.